Sphygmomanometer Market Report 2026

Sphygmomanometer Market Overview

• Sphygmomanometer market size has reached to $3.2 billion in 2025 • Expected to grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: The Rising Burden Of Chronic Non-Communicable Diseases Is Driving The Market Due To Increasing Hypertension Prevalence Requiring Continuous Blood-Pressure Monitoring • Market Trend: Innovations In AI-Enabled Automatic Monitoring Devices Enhance Cardiovascular Screening Accuracy And Home-Based Disease Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sphygmomanometer Market?

A sphygmomanometer refers to a device used for measuring blood pressure, particularly the pressure in arteries. It consists of an inflatable cuff to restrict blood flow and a gauge to measure the pressure. The main products of sphygmomanometers are electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer refers to a medical device used to measure blood pressure and is used in clinical settings and at home for self-monitoring of blood pressure. They are configured as portable, desk-mounted, floor-standing, and wall mounted and operated electric, manual, automatic, and semi-automatic used by hospitals, ambulatory surgical centers, clinics, home healthcare, and other end users.

What Is The Sphygmomanometer Market Growth Forecast?

The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of connected healthcare devices, expansion of telemedicine services, growing focus on preventive cardiovascular care, increasing replacement of mercury-based devices. Major trends in the forecast period include increasing adoption of digital blood pressure monitoring devices, rising demand for home-based monitoring solutions, growing integration of data connectivity features, expansion of portable and wearable configurations, enhanced focus on measurement accuracy and ease of use.

Global Sphygmomanometer Market Segmentation

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer 2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted 3) By Operation: Electric, Manual, Automatic, Semi-automatic 4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users Subsegments: 1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer 2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer 3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Are The Drivers Of The Sphygmomanometer Market?

The rising burden of chronic non-communicable diseases (NCDs) is expected to propel the growth of the sphygmomanometer market going forward. Chronic NCDs—particularly hypertension and cardiovascular disease—refer to long-lasting health conditions that progress slowly and require ongoing monitoring and management. Hypertension is a major global health concern and a primary risk factor for cardiovascular complications, making regular blood-pressure assessment essential for early detection and effective treatment. The growing prevalence of these conditions is driven by lifestyle factors such as aging populations, unhealthy diets, physical inactivity, and rising obesity rates, which contribute to increased blood-pressure irregularities worldwide. Sphygmomanometers support patient care by enabling timely diagnosis, continuous monitoring, and improved cardiovascular risk management in both clinical and home-care settings. For instance, in September 2025, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations, reflecting the substantial global burden of hypertension, an estimated 1.4 billion adults aged 30–79 were affected in 2024—representing 33 percent of this age group—with two-thirds residing in low- and middle-income countries, while roughly 600 million individuals (44 percent) remained undiagnosed and about 630 million (44 percent) received diagnosis and treatment. Therefore, the rising burden of chronic NCDs is driving the growth of the sphygmomanometer industry. The growing number of ambulatory surgery centers is expected to propel the growth of the sphygmomanometer market going forward. An Ambulatory Surgical Center (ASC) is a medical facility dedicated to performing surgical procedures that do not require an overnight stay in a hospital. Ambulatory surgery centers (ASCs) rely heavily on sphygmomanometers, also known as blood pressure cuffs, to monitor patients' vital signs before, during, and after surgery. For instance, in July 2025, according to CliftonLarsonAllen LLP, a US-based professional services firm, ambulatory surgery centers are expanding in scale and utilization, with over 10,000 facilities operating across the United States and industry revenues forecast to rise from approximately USD 45 billion in 2024 to about USD 57 billion by 2030. Therefore, the growing number of ambulatory surgery centers is driving the growth of the sphygmomanometer industry.

Key Players In The Global Sphygmomanometer Market

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Global Sphygmomanometer Market Trends and Insights

Major companies operating in the sphygmomanometer market are focusing on developing advanced automatic blood pressure monitoring solutions that integrate AI-driven diagnostic features to improve measurement accuracy, support early detection of cardiovascular abnormalities, and enhance the convenience of home-based health monitoring. AI-enabled automatic blood pressure monitors use machine-learning algorithms to analyze pulse-wave signals during cuff inflation, allowing the device to detect irregular heart rhythms such as atrial fibrillation (AFib) while providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, received FDA De Novo authorization for its next-generation home blood pressure monitor equipped with IntelliSense AFib, an AI-powered AFib detection algorithm that evaluates more than 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are evolving from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Regional Outlook

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Sphygmomanometer Market?

The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.